Viewing Opinion | StockChase

Gilead Sciences Inc. (GILD-Q) opinion on 2017-01-11

Last Price Recorded: 81.7400 on 2018-01-17

ON STOCKCHASE SINCE Dec 2008

biotechnology/pharmaceutical
biotechnology/pharmaceutical
COMMENT

Christine Poole
Gilead Sciences Inc. was $73.770 at time of opinion
Owned : No

Trading at a pretty low PE multiple, but are experiencing a lot of competition on a few of their key branded drugs. There is not a lot of visibility going forward on what earnings are going to look like. The pharmacy industry seems to be going through a transition. We are seeing consolidation, because that is a way to grow where they can get synergies and cut costs. Not only does this have uncertainty regarding pricing, but are also experiencing competition in their own branded drugs.

UNKNOWN

All opinions for GILD-Q (203)

24 BUY
2 BUY on WEAKNESS
53 COMMENT
27 DON'T BUY
17 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
25 PAST TOP PICK
7 SELL
1 STRONG BUY
30 TOP PICK
4 WAIT
6 WATCH
4 WEAK BUY
View All

More experts covering GILD-Q

SAVE
Add GILD-Q to Watch List

All opinions for GILD-Q (203)

24 BUY
2 BUY on WEAKNESS
53 COMMENT
27 DON'T BUY
17 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
25 PAST TOP PICK
7 SELL
1 STRONG BUY
30 TOP PICK
4 WAIT
6 WATCH
4 WEAK BUY
View All

More experts covering GILD-Q

SAVE
Add GILD-Q to Watch List

Last 60 Days Opinions

DON'T BUY
6 days ago
PAST TOP PICK
2 weeks ago
DON'T BUY
4 weeks ago
WAIT
1 month ago
WATCH
1 month ago
WATCH
1 month ago
DON'T BUY
1 month ago

No Comments.


You must be logged in to comment.

Successfully Saved Company